US Stock MarketDetailed Quotes

FIVN Five9

Watchlist
  • 36.200
  • -0.390-1.07%
Close Feb 28 16:00 ET
  • 36.400
  • +0.200+0.55%
Post 20:01 ET
2.74BMarket Cap-212.94P/E (TTM)

Five9 Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Five9 Q4 2024 Earnings Date

Currency：USDFeb 20, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
267.70M
278.66M
+10.96M
Beat Est.
+11.98%
+16.56%
+4.10%
EPS
0.05
0.13
+0.08
Beat Est.
+132.02%
+176.47%
+138.97%
Analyst Rating
Strong Buy

Feb 28, 2025

Five9 Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 20 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 276.395M--
--2025/Q1-- / 272.247M--
Feb 20, 20252024/Q4278.660M / 267.697M--
Nov 7, 20242024/Q3264.182M / 255.067M--
Aug 8, 20242024/Q2252.086M / 245.112M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 276.395M--
--2025/Q1-- / 272.247M--
Feb 20, 20252024/Q4278.660M / 267.697M--
Nov 7, 20242024/Q3264.182M / 255.067M--
Aug 8, 20242024/Q2252.086M / 245.112M--

Unlock Free Earnings Estimates

Five9 Earnings Reports

  • Five9 | 10-K: FY2024 Annual Report

    Feb 21 12:58 ET

  • Five9 | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 16:24 ET

  • Five9 | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 16:19 ET

  • Five9 | 8-K: Five9 Reports First Quarter 2024 Results

    May 2, 2024 17:19 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Strong Buy

    • Buy

      77.78%

    • Hold

      22.22%

    • Sell

      0.00%

    Price Target

    No Data